UBS Group’s BIMI International Medical Inc. Common Stock BIMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-911
| Closed | -$2K | – | 10241 |
|
|
2023
Q4 | $2K | Buy |
+911
| New | +$1.56K | ﹤0.01% | 8184 |
|
|
2023
Q3 | – | Sell |
-2,484
| Closed | -$3.48K | – | 10139 |
|
|
2023
Q2 | $3.48K | Buy |
2,484
+79
| +3% | +$73 | ﹤0.01% | 7625 |
|
|
2023
Q1 | $1.32K | Sell |
2,405
-835
| -26% | -$1K | ﹤0.01% | 8765 |
|
|
2022
Q4 | $3.98K | Buy |
3,240
+635
| +24% | +$1.54K | ﹤0.01% | 9410 |
|
|
2022
Q3 | $7K | Sell |
2,605
-11
| -0.4% | -$54 | ﹤0.01% | 8925 |
|
|
2022
Q2 | $17K | Buy |
2,616
+2,500
| +2,155% | +$19.7K | ﹤0.01% | 7130 |
|
|
2022
Q1 | $2K | Sell |
116
-821
| -88% | -$13.4K | ﹤0.01% | 9704 |
|
|
2021
Q4 | $24K | Buy |
937
+855
| +1,043% | +$30.5K | ﹤0.01% | 7650 |
|
|
2021
Q3 | $3K | Buy |
+82
| New | +$3.88K | ﹤0.01% | 8858 |
|
|
2021
Q2 | – | Sell |
-386
| Closed | -$34K | – | 9945 |
|
|
2021
Q1 | $34K | Buy |
+386
| New | +$36.6K | ﹤0.01% | 6908 |
|
|
2020
Q4 | – | Sell |
-15
| Closed | -$1K | – | 8864 |
|
|
2020
Q3 | $1K | Buy |
+15
| New | +$1.42K | ﹤0.01% | 7858 |
|
|
2020
Q2 | – | Sell |
-79
| Closed | -$10K | – | 8457 |
|
|
2020
Q1 | $10K | Buy |
79
+65
| +464% | +$10.6K | ﹤0.01% | 6943 |
|
|
2019
Q4 | $2K | Buy |
14
+7
| +100% | +$1.25K | ﹤0.01% | 7866 |
|
|
2019
Q3 | $0 | Buy |
+7
| New | +$727 | ﹤0.01% | 8337 |
|
|
2017
Q4 | – | Sell |
-157
| Closed | -$7K | – | 8159 |
|
|
2017
Q3 | $7K | Buy |
157
+63
| +67% | +$2.69K | ﹤0.01% | 7094 |
|
|
2017
Q2 | $4K | Sell |
94
-24
| -20% | -$1.21K | ﹤0.01% | 7229 |
|
|
2017
Q1 | $6K | Buy |
118
+74
| +168% | +$3.83K | ﹤0.01% | 6922 |
|
|
2016
Q4 | $2K | Buy |
+44
| New | +$2.14K | ﹤0.01% | 7529 |
|
|
2016
Q3 | – | Sell |
-68
| Closed | -$3K | – | 7994 |
|
|
2016
Q2 | $3K | Buy |
68
+33
| +94% | +$1.21K | ﹤0.01% | 7347 |
|
|
2016
Q1 | $1K | Sell |
35
-49
| -58% | -$1.81K | ﹤0.01% | 7473 |
|
|
2015
Q4 | $3K | Buy |
84
+13
| +18% | +$641 | ﹤0.01% | 7909 |
|
|
2015
Q3 | $4K | Buy |
71
+43
| +154% | +$2.7K | ﹤0.01% | 7858 |
|
|
2015
Q2 | $2K | Buy |
28
+25
| +833% | +$2.23K | ﹤0.01% | 8227 |
|
|
2015
Q1 | $0 | Sell |
3
-22
| -88% | -$2.08K | ﹤0.01% | 9502 |
|
|
2014
Q4 | $2K | Buy |
+25
| New | +$2.64K | ﹤0.01% | 9437 |
|
Other funds holding BIMI
N
FP
UBS Group's BIMI Position: Q1 2024 in Review
UBS Group sold out of BIMI International Medical Inc. Common Stock (BIMI) in Q1 2024, closing a stake of 911 shares — an estimated $2K sold.
UBS Group first reported a position in BIMI in Q4 2014 and held it in 25 quarters. The position peaked at $34K in Q1 2021. 6 funds tracked by Wall St. Rank hold BIMI as of Q1 2024.
- UBS Group reported no remaining BIMI International Medical Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- UBS Group sold 911 BIMI International Medical Inc. Common Stock shares in Q1 2024, an estimated $2K.
- UBS Group first reported a position in BIMI International Medical Inc. Common Stock in Q4 2014 and held it in 25 quarters.
- UBS Group's BIMI International Medical Inc. Common Stock position peaked at $34K in Q1 2021.
- 6 funds tracked by Wall St. Rank held BIMI International Medical Inc. Common Stock as of Q1 2024.
Based on UBS Group's 13F filing for Q1 2024, filed 13 May 2024.